Is there an association between lymph node size and hyperprogression in immunotherapy-treated patients?
Authors
Mohammad S. Alkader
mohammadalkhader1984@gmail.com
Department of Clinical Oncology, Military Cancer Center, Royal Medical Services, Amman, Jordan
Rashed Z. Altaha
Department of Internal Medicine, Military Cancer Center, Royal Medical Services, Amman, Jordan
Eslam H. Jabali
Department of nuclear medicine, Royal Medical Services, Amman, Jordan
Ola A. Attieh
Department of nuclear medicine, Royal Medical Services, Amman, Jordan
Ala’ W. Matalqa
Department of Internal Medicine, Military Cancer Center, Royal Medical Services, Amman, Jordan
Language: English
Page range: 33 - 43
Submitted on: Jul 22, 2023
Published on: Mar 23, 2024
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2024 Mohammad S. Alkader, Rashed Z. Altaha, Eslam H. Jabali, Ola A. Attieh, Ala’ W. Matalqa, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.